FP55-FR-05 The management of symptomatic severe degenerative disc disease with botulinum toxin type A: a case studydoi:10.1016/s0022-510x(09)70563-5M. JaffeElsevier
FP55-FR-05 The management of symptomatic severe degenerative disc disease with botulinum toxin type A: a case studydoi:10.1016/S0022-510X(09)70563-5M. JaffeElsevier B.V.Journal of the Neurological Sciences
Circulating miR-155-5p as a Novel Biomarker of Lumbar Degenerative Disc Disease. Spine 2020, 45, E499–E507. [Google Scholar] [CrossRef] Ramos, Y.F.M.; Coutinho de Almeida, R.; Lakenberg, N.; Suchiman, E.; Mei, H.; Kloppenburg, M.; Nelissen, R.G.H.H.; Meulenbelt, I. ...